Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 12, 2026
Targeting RAS-RAF-MEK-ERK signaling in mucinous ovarian cancer: a translational evidence synthesis and clinical frameworkThomas Bartl, Dan Cacsire Castillo-TongAnticancer Research|May 6, 2020
Gene Expression of Kallikreins in Breast Cancer Cell LinesRafał Watrowski, Dan Cacsire Castillo-Tong, Eva Obermayr, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 13, 2015
The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian womenRafał Watrowski, Dan Cacsire Castillo-Tong, Gerhild Fabjani, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 16, 2015
Association of HER2 codon 655 polymorphism with ovarian cancerRafał Watrowski, Dan Cacsire Castillo-Tong, Eva Schuster, et al.Journal of Personalized Medicine|April 23, 2022
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast CancerMichael Kenn, Rudolf Karch, Dan Cacsire Castillo-Tong, et al.Breast Cancer Research and Treatment|August 18, 2018
Co-expressed genes enhance precision of receptor status identification in breast cancer patientsMichael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, et al.Biomed Research International|August 25, 2020
Microarray Normalization Revisited for Reproducible Breast Cancer BiomarkersMichael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, et al.Scientific Reports|February 20, 2021
Decision theory for precision therapy of breast cancerMichael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, et al.Anticancer Research|October 28, 2015
HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian WomenRafał Watrowski, Dan Cacsire Castillo-Tong, Andrea Wolf, et al.Oncotarget|November 5, 2017
Gene expression information improves reliability of receptor status in breast cancer patientsMichael Kenn, Karin Schlangen, Dan Cacsire Castillo-Tong, et al.Pageof 6